CLEARWATER, Fla.--(EON: Enhanced Online News)--Bovie Medical Corporation (“Bovie” or the “Company”) (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced today that Robert L. Gershon, Chief Executive Officer of the Company, will present at the 29th Annual Roth Capital Conference in Dana Point, California on Tuesday, March 14, at 3:30 p.m. Pacific Time.
To access the webcast, please go to http://wsw.com/webcast/roth31/bvx. A replay of the webcast and presentation will be posted following the event via Bovie Medical’s website.
The conference will be held March 12-15, 2017 at The Ritz Carlton and is by invitation only. Bovie Medical’s management team will be available for one-on-one meetings. Investors interested in arranging a meeting should contact their ROTH representative.
About Bovie Medical Corporation
Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product for cutting and coagulation. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company’s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie Medical Corporation’s website www.boviemed.com.